Codiak BioSciences gets grant for extracellular vesicles for disease treatment and prevention

Discover Codiak BioSciences’ groundbreaking patent on engineered extracellular vesicles (EVs) for targeted disease treatment, including cancer and infections.

Low-Dose RT Boost Wins Support for Young Patients With Early Breast Cancer

A low-dose radiotherapy (RT) boost to the tumor bed provided adequate control of breast cancer recurrence in younger patients with better cosmetic results as compared

March 22, 2024

Numab extends its Series C; AnaCardio raises $19M for its heart failure drug

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 10, 2025

SPY ETF & QQQ ETF and what might cause a stock market crash

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.